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EPIDERMAL carcinogenesis in the mouse has been divided into two stages
(Berenblum, 1954). In the first, the skin is prepared so that in the second a
suitable non-carcinogenic or weakly carcinogenic agent is able to elicit a high
incidence of epidermal tumours in the prepared skin. Most of the agents found
able to prepare the skin in this way have been applied topically, but in three
instances the agent was given by another route. 2-Acetylaminofluorene given
by mouth (Ritchie and Saffiotti, 1955), 9,10-dimethyl-1,2-benzanthracene given
orally, intraperitoneally or intravenously (Graffi, Scharsach and Heyer, 1955) and
urethane given by mouth (Haran and Berenblum, 1956) have all been reported
able to prepare mouse skin in this way. The present paper describes a fourth
manner in which mouse skin can be prepared in this way by an agent which is
not applied topically. Intraperitoneally administered urethane has been found
adequate to prepare mouse skin so that subsequent topical applications of croton
oil are able to elicit a higher incidence of papillomata than croton oil can elicit
in unprepared skin.
METHOD
Virgin, adult, female mice of the Swiss strain obtained from the Roscoe B.
Jackson Memorial Laboratory, Bar Harbor, Maine, were used. In each experi-
ment, the mice of the experimental and control groups were drawn at random
from a common pool, all animals weighing about 20 g. The mice were fed
Rockland Mouse Diet, being given food and water ad libitum. They were weighed
weekly, but no abnormal alteration in their weight was noted at any time during
the experiments. "Urethan Merck" (Ethyl carbamate) U.S.P. (lot 6839) was
injected as a 10 per cent w/v solution in distilled water, 0.3 ml. being given
intraperitoneally. 01. croton. B.P.C. (Boot's Pure Drug Co., batch 5596A) was
applied as a 5 per cent v/v solution in heavy liquid paraffin B.P. (British Drug
Houses (Canada) lot 12578), being spread sparely over the whole back with a
fine camel's hair brush. The painted area was kept shorn with electric clippers or
scissors. Control mice in groups not painted with croton oil were clipped in the
same way as those painted. The mice were examined twice a week, and any
changes in the number, size, type or position of the tumours charted on special
diagrams.
EXPERIMENTAL
The skin tumours all arose within the area painted with croton oil. All were
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the type described by Shubik, Baserga and Ritchie (1953). A few progressed to
become pedunculated papillomata and a few became carcinomata. No carcinoma
arose except from a pre-existing papilloma. As is usual in experiments in which
croton oil is applied to suitably prepared mouse skin, many of the papillomata
regressed, perhaps to recur and persist or to recur and again regress. In calcu-
lating the results, no papilloma has been included unless it persisted for at least
10 days. The tables record the total number of papillomata which appeared.
No deduction has been made for papillomata which regressed, or for papillomata
present on mice which died. Papillomata which recurred have not been counted
as new tumours. Details as to the number of regressions and recurrences will be
given in the text. In addition, the tables record the total number of papillomata
on the survivors and, to facilitate comparison between groups, the average
number of papillomata per survivor, a figure obtained by dividing the total
number of papillomata which had appeared on the survivors by the number of
survivors. Once again, no deduction has been made for papillomata which
regressed and papillomata recurring have not been counted as new tumours.
The latent period of a papilloma has been taken to be the period between the
first application of croton oil and its first appearance. In calculating the average
latent period, every papilloma has been considered, not only those which were
the first to appear on their host. Forpapillomatawhich regressed andsubsequently
recurred, the latent period has been taken to be the time up to their first
appearance.
Experiment " A "
In the experimental group, 20 mice were given a single intraperitoneal injec-
tion of 30 mg. of urethane. Applications of croton oil were begun 31 days later
and were continued twice a week until the end of the experiment. A control
group of 49 mice was given no urethane, but was painted with croton oil just as
was the experimental group.
Table I shows the results. Many papillomata were produced in both the experi-
mental and control groups, but it is apparent that the average number of papil-
lomata per survivor was nearly three times as great in the experimental group
as in the control. Of the 50 papillomata in the experimental group, 21 (42 per
cent) regressed. Six of the 21 recurred, but one again regressed. In the control
group, 17 of the 63 (27 per cent) papillomata regressed. Three of the 17
recurred, one to regress a second time, recur again, and regress a third time. In
the experimental group, three of the papillomata became carcinomata, the first
carcinoma appearing on day 297. In the control group, one carcinoma appeared
on day 364. In the experimental group, the average latent period as measured
from the first application ofcroton oil was 121 days, in the control group 210 days.
Experiment " B "
To confirm the findings of Experiment "A ", the work was repeated. An
experimental group of30 mice was given a single intraperitoneal injection of 30 mg.
of urethane, and 31 days later applications of croton oil were begun and were
continued twice a week. A control group of 19 mice was painted. with croton oil
but received no urethane, and an additional control group of 20 mice was given
urethane but no croton oil.208
Procedure Time*
I.P. urethane 0
followed by 50
croton oil 100
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TABLE I.-Experiment "A"
Total Total Papilloma-
papillomata papillomata bearing Papillominata
Survivors appearing on survivors survivors per survivor
20 - - -
20 - - -
16 . 25 . 25 . 9 . 1-6
150 . 16
200 . 16
250 . 14
300 . 11
350 . 9
375 . 6
37
44
48
48
50
50
37
44
37
37
32
26
10
11
10
10
8
6
2-3
2-8
2-6
3 4
3-6
4-3
Croton oil only 0 . 49
50 46
100 . 46
150
200
250
45
43
41
6
18
40
47
6
18
29
36
300 . 39 . 53 . 42
350 . 36 . 58 . 47
375 . 34 . 63 . 52
* Days after the first application of croton oil.
TABLE II.-Experiment "B"
Procedure Time*
I.P. urethane 0
followed by 50
croton oil 100
Croton oil only
Total Total Papilloma-
papillomata papillomata bearing Papillomata
Survivors appearing on survivors survivors per survivor
30 . - . .
30 . . - . .
30 . 46 . 46 . 19 . 1.5
150 . 29
200 . 28
250 . 25
0 . 19
50 19
100 . 18
60
75
92
3
60
73
90
3
20
21
20
2-1
2-6
3-6
2 0-2
150 . 18
200 . 16
250 . 14
0 . 20
50 . 20
100 . 20
7 .. 7
11 . 11
19 . 19
150 . 19
200 . 16
250 . 14
* Days after first application of croton oil or in group given urethane only from 31 days after
the injection.
3
7
13
16
19
18
17
0*1
0.4
0- 7
0.9
1-1
1-3
1.5
Urethane only
4
6
7
0-4
0 7
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The results are shown in Table II. Again, papillomata were produced both
in the experimental group and in the control group given only croton oil. No
tumnours appeared in the skin of mice given urethane but no croton oil. As in
Experiment "A ", the average number of papillomata per survivor was some
three times as great in the experimental group as in the control group given only
croton oil. Of the 92 papillomata of the experimental group, 48 (52 per cent)
regressed, six to recur. Four of the six again regressed, but two of these recurred
a second time and have persisted. In the control group, 3 (16 per cent) of the
19 papillomata regressed, and none recurred. No carcinomata were induced.
The average latent period as measured from the first application of croton oil
was 128 days in the experimental group, and 175 days in the control group given
only croton oil.
Experiment " C
Further evidence that urethane administered intraperitoneally can prepare
mouse skin so that subsequent applications of croton oil become able to elicit a
higher incidence of papillomata than croton oil alone can elicit in unprepared
skin, was obtained by giving a larger dose of urethane. As the 30 mg. dose used
in Experiments " A " and " B " anaesthetizes the mice for some hours, it was
not possible to increase the dose given as a single injection, and so repeated
injections were given. Unfortunately, so many of the mice died that it was not
possible to set up a control group given urethane but not croton oil, but published
reports suggest that even repeated injections of urethane are unable to produce
skin tumours in mice (Shimkin, 1955). The experiment was performed simnul-
taneously with Experiment " A " and on mice from the same pool, and so the
control group given only croton oil of Experiment " A " will serve for this
experiment also.
In the experimental group, 10 intraperitoneal injections of 30 mg. of urethane
were given, on days 0, 7, 14, 21, 60, 66, 73, 80, 88 and 94. Croton oil was started
31 days after the last injection and was applied twice a week as in Experiment
~¢ A ,,. A
TABLE III.-Experiment "C "
Total Total Papilloma-
papillomata papillomata bearing Papillomata
Procedure Time* Survivors appearing on survivors survivors per survivor
I.P. urethane 0 14 . - . . .
x 10 followed 50 . 11 . 3 . 3 . 1 . 0.3
by croton oil 100 11 . 54 . 54 . 6 . 4.9
150 . 6 . 75 . 39 5 . 6-5
175 . 6 . 75 . 39 5 . 6-5
* Days after the first application of croton oil.
Table III shows the results. The average number ofpapillomata per survivor
was much greater than in the comparable groups given only one injection of
urethane in Experiments "A " and "B ", and very much greater than in the
control group given only croton oil. Of the 75 papillomata, 13 (17 per cent)
regressed and none recurred. The average latent period measured from the first
application of croton oil was 88 days.
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Histology
Sections of skin taken at various intervals up to three weeks after a single
intraperitoneal injection of 30 mg. of urethane showed no microscopically visible
abnormality when stained with haematoxylin and eosin.
DISCUSSION
These experiments show that urethane administered intraperitoneally is able
to prepare mouse skin so that subsequent topical applications of croton oil are
able to elicit a greater incidence of papillomata than can croton oil applied to
unprepared mouse skin. When one intraperitoneal injection of urethane was used
to prepare the skin, the average number of papillomata per survivor elicited by
croton oil was some three times as great as when croton oil was applied to unpre-
pared skin, and when ten injections of urethane were used to prepare the skin,
some ten times as great. A few of the papillomata progressed to carcinomata.
The considerable number of papillomata induced by croton oil in normal,
unprepared skin deserves comment. Several workers have found croton oil able
to induce papil]omata in normal mouse skin (Boutwell, Rusch and Bosch, 1955;
Roe, 1956), but in sharp contrast are previous experiments by my colleagues and
me in which we found croton oil unable to induce any tumours in normal mouse
skin (Berenblum and Shubik, 1947a; Shubik, Goldfarb, Ritchie and Lisco, 1953;
Ritchie and Saffiotti, 1955). The discrepancy may be due to differences in the
sensitivity of the mice used, to differences in the technique by which the croton
oil is applied, or to differences between one batch of croton oil and another.
Croton oil is a complex mixture of uncertain composition, and one sample may
well differ from another. The only differences between the control groups reported
by Shubik, Goldfarb, Ritchie and Lisco (1953) and Ritchie and Saffiotti (1955)
and those of the present experiments seem to be that different batches of croton
oil were used, and that the earlier work was done in Chicago, the present in
Montreal.
The theory of the stages of carcinogenesis is not weakened by the observation
that croton oil can induce papillomata in normal mouse skin. The theory postu-
lates that at least some papillomata arise in two stages, a first in which individual
cells or groups of cells are changed into an intermediate state and a second in
which these changed cells are made manifest as papillomata (Berenblum and
Shubik, 1947b). The first stage is usually called "initiation ", the second
"promotion " (Friedewald and Rous, 1944). In the present experiments, the
incidence ofpapillomata was greater when croton oil was applied to skin prepared
by an injection of urethane than when it was applied to unprepared skin. This
increase can be explained by assuming that the urethane changed some of the
cells in the epidermis to the intermediate state, and that croton oil was able to
make these changed cells manifest as papillomata. That is, the urethane served
as initiating agent, the croton oil as promoting agent. There is no evidence as
to whether the papillomata induced by croton oil in unprepared skin were
produced in the same staged fashion or were the result of a single change whereby
normal cells became papilloma cells.
Finally, it is noteworthy that though for several years intraperitoneal injec-
tions of urethane have been used to induce adenomata of the lung in mice
(Shimkin, 1955), at no time was it suspected that the drug had any effect on the
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skiln. In the same way, 2-acetylaminofluorene was fed to mice, and tumours
induced in various parts of the body (Bielschowsky, 1947), but not until croton
oil was applied to the skin of mice so fed was it suspected that this compound had
initiated the carcinogenic process in the skin (Ritchie and Saffiotti, 1955).
Further, neither orally administered 2-acetylaminofluorene nor intraperitoneally
administered urethane produces any obvious histological alteration in the skin.
It may be that remotely acting agents of this type which produce no histological
abnormality in the target organ play some part in the induction of "spon-
taneous" tumours in man.
SUMMARY
1. A single intraperitoneal injection of urethane was able to prepare mouse
skin so that subsequent topical applications of croton oil were able to elicit some
three times as many papillomata per survivor as could croton oil applied to
unprepared mouse skin.
2. When ten intraperitoneal injections of urethane were used to prepare the
skin, subsequent topical applications of croton oil were able to elicit some ten
times as many papillomata per survivor as could croton oil applied to unprepared
skin.
3. A few of the papillomata became carcinomata.
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